Bioqual Price to Free Cash Flow Ratio 2010-2023 | BIOQ
Historical price to free cash flow ratio values for Bioqual (BIOQ) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Bioqual Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.063B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.537B | 10.61 |
| Quest Diagnostics (DGX) | United States | $15.695B | 16.22 |
| DaVita (DVA) | United States | $12.150B | 15.09 |
| Encompass Health (EHC) | United States | $8.507B | 21.78 |
| Chemed (CHE) | United States | $8.408B | 26.06 |
| Elanco Animal Health (ELAN) | United States | $8.297B | 21.53 |
| Option Care Health (OPCH) | United States | $5.048B | 19.10 |
| RadNet (RDNT) | United States | $4.325B | 90.06 |
| Amedisys (AMED) | United States | $3.145B | 22.27 |
| Astrana Health (ASTH) | United States | $2.239B | 30.28 |
| LifeStance Health (LFST) | United States | $2.179B | 0.00 |
| Addus HomeCare (ADUS) | United States | $1.827B | 26.14 |
| U.S Physical Therapy (USPH) | United States | $1.534B | 41.06 |
| Pennant (PNTG) | United States | $0.706B | 37.29 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.539B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.270B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.026B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.021B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |